Piper Sandler Maintains Overweight on Alkermes, Lowers Price Target to $43

Alkermes Public Limited Company

Alkermes Public Limited Company

ALKS

0.00

Piper Sandler analyst David Amsellem maintains Alkermes (NASDAQ: ALKS) with a Overweight and lowers the price target from $45 to $43.